Fatigue in cancer patients treated with cytotoxic drugs

Journal of Oncology Pharmacy Practice

Volumn 12, Issue 3, 2006, Pages 155-164

  Hartvig, Per ^a   Aulin, Johan ^a,b   Hugerth, Matilda ^b   Wallenberg, Sofia ^b   Wagenius, Gunnar ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cytotoxic drugs; Fatigue; Quality of life; Self report; Side effects

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GEMCITABINE; IRINOTECAN; METHOTREXATE; NAVELBINE; PACLITAXEL;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CORRELATION FUNCTION; DAILY LIFE ACTIVITY; DATA COLLECTION METHOD; DEPRESSION; DIGESTIVE SYSTEM CANCER; DISEASE SEVERITY; FATIGUE; FEMALE; FEMALE GENITAL TRACT CANCER; FREQUENCY ANALYSIS; HUMAN; LONGITUDINAL STUDY; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT COUNSELING; PHARMACIST; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RATING SCALE; SYMPTOM;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; FATIGUE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 33750738120     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1177/1078155206070774     Document Type: Article

References (32)

1. Patrick DL, Ferketich SL, Frame PS, et al. National Institutes of Health State-of-the-Science Conference Statement: symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002. J Nat Cancer Inst 2003; 95: 1110-17.
2. Simon A, Zittoun R. Fatigue in cancer patients. Curr Opin Oncol 1999; 11: 244-49.
3. Ream E, Richardson A. From therapy to practice: designing interventions to reduce fatigue in patients with cancer. Oncol Nurs Forum 1999; 26: 1295-303.
4. Irvine D, Vincent L, Graydon J, et al. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy drugs and radiotherapy. Cancer Nurs 1994; 17: 367-78.
5. Kalman D. Nutritional aspects of cancer-related fatigue. J Am Diet Assoc 1997; 97: 650-54.
6. Rhodes V, Watson PM, Hanson BM. Patients' description of the influence of tiredness and weakness on self-care abilities. Cancer Nurs 1988; 11: 186-94.
7. Aistars J. Fatigue in the cancer patient: a conceptual approach to a clinical problem. Oncol Nurs Forum 1987; 14: 25-29.
8. Dimeo F, Stieglitz RD, Novelli-Fischer U, Fetscher S, Keul J. Effects of physical activity on the fatigue and psychological status of cancer patients during cytotoxic drugs. Cancer 1999; 85: 2273-77.
9. Richardson A. Measuring fatigue in patients with cancer. Support Care Cancer 1998; 6: 94-100.
10. Piper B, Lindsey AM, Dodd M. Fatigue mechanisms in cancer patients: developing nursing theory. Oncol Nurs Forum 1987; 14: 17-23.
11. Richardson A. Fatigue in cancer patients: a review of the literature. Eur J Cancer Care 1995; 4: 20-32.
12. Hartvig P, Aulin J, Wallenberg S, et al. Physical exercise for cytotoxic drug induced fatigue. J Oncol Pharm Pract (submitted 10.1177/ 1078155206070766).
13. Hann D, Jacobsen PB, Azzarello LM. Measurement of fatigue in cancer patients: development and validation of the fatigue symptom inventory. Qual Life Res 1998; 7: 301-10.
14. Schwartz A, Nail LM, Chen S, et al. Fatigue patterns observed in patients receiving chemotherapy drugs and radiotherapy. Cancer Invest 2000; 18: 11-19.
15. Piper B. Fatigue and cancer: inevitable companions? Support Care Cancer 1993; 1: 285-86.
16. Cella D, Peterman A, Passik S, et al. Progress toward guidelines for the management of fatigue. Oncology 1998; 12: 369-77.
17. Ream E, Richardson A. Fatigue: a concept analysis. Int J Nurs Stud 1996; 33: 519-29.
18. Rhoten D. Fatigue and the postsurgical patient, In Norris C ed. Concept clarification in nursing. Aspen, 1982: 277-300.
19. Krupp L, LaRocca NG, Muir-Nash J, et al. The Fatigue Severity Scale. Arch Neurol 1989; 46: 1121-23.
20. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psych Res 1992; 37: 147-53.
21. Glaus A. Fatigue in patients with cancer. Analysis and assessment. Recent results. Cancer Res 1998; 145: I-XI, 1-172.
22. Kogi K, Saito Y, Mitsuhashi T. Validity of three components of subjective fatigue feelings. J Sci Lab 1970; 46: 251-70.
23. Yellen S, Cella DF, Webster K, et al. Measuring fatigue and other anaemia-related symptoms with the functional assessment of cancer therapy. J Pain Symptom Manage 1997; 13: 63-74.
24. Smets E, Garssen B, Boake B, et al. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psych Res 1995; 39: 315-25.
25. Stein K, Martin SC, Hann DM, et al. A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 1998; 6: 143-52.
26. Piper BF. Piper fatigue scale for clinical testing. Oncol Nurs Forum 1990; 17: 661-62.
27. Piper B, Dibble SL, Dodd MJ, et al. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 1998: 25: 677-84.
28. Schwartz A. The Schwartz cancer fatigue scale: testing reliability and validity. Oncol Nurs Forum 1998; 25: 711-17.
29. Richardson A. The experience of fatigue and other symptoms in patients receiving chemotherapy. Eur J Cancer Care 1996; 5: 24-30.
30. Richardson A, Ream E, Wilson-Barnett J. Fatigue in patients receiving chemotherapy: patterns of change. Cancer Nurs 1998; 21: 17-30.
31. Smets E, Garssen B, Cull A, et al. Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer 1996; 73: 241-45.
32. Jacobsen P, Hann DM, Azzarello LM, et al. Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course and correlates. J Pain Symptom Manage 1999; 18: 233-42.